Corbus Pharmaceuticals Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Corbus Pharmaceuticals Holdings Inc 's ROA in the second quarter of 2026?
Corbus Pharmaceuticals Holdings Inc recorded a cumulative net loss of $-102 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -73.9%.

However, within the Healthcare sector 678 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4044, from total ROA ranking in the first quarter of 2026 at 4680.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	5.57 %	3.62 %	8.26 %	-33.44 %	-16.61 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-102	-85	-79	-68	-58
Return On Assets (TTM)	-73.9 %	-62.08 %	-58.22 %	-51.26 %	-39.86 %
CRBP's Total Ranking	# 4044	# 4680	# 4030	# 3944	# 3899
Total Assets (TTM) in million	132	144	167	109	125
Seq. Total Assets Change	-8.1 %	-14.02 %	53.64 %	-13.04 %	-9.8 %
Seq. Net Income Change	-	-	-	-	-

CRBP's 5 Years Annual ROA >> Back to CRBP Management Effectiveness >> Compare CRBP ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 309
Sector	# 679
Overall	# 4116

Return On Assets Statistics
High	Average	Low
36.36 %	-72.29 %	-167.68 %
(Sep 30 2015)		(Sep 30 2020)

Financial Statements
Corbus Pharmaceuticals Holdings Inc 's Assets	$ 132 million	CRBP's Balance sheet
Corbus Pharmaceuticals Holdings Inc 's Income	$ -35 million	Quarterly CRBP's Income Statement
CRBP's Income by Division		See CRBP's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	8.26 %	453.63 %	-56.29 %	-38.42 %	6.64 %
Total Assets in million	167	154	28	64	104
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-79	-40	-45	-42	-46
Annual Return On Assets	-47 %	-26.05 %	-159.97 %	-66.38 %	-44.06 %

CRBP's 5 Years Annual ROA >> Back to CRBP Management Effectiveness >> Compare CRBP ROA to its Competitors

More Return On Assets Ratios
CRBP's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CRBP's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CRBP's Competitors
Subscribers only: Roa for Corbus Pharmaceuticals Holdings Inc 's Suppliers
Subscribers only: Return On Assets for CRBP's Customers

You may also want to know
CRBP's Roi	CRBP's Inventory Turnover Ratio	CRBP's Growth Rates	CRBP's Dividend Comparisons
	CRBP's Profitability Ratios	CRBP's Asset Turnover Ratio	CRBP's Dividend Growth
CRBP's Roe	CRBP's Valuation Ratios	CRBP's Financial Strength Ratios	CRBP's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-08T01:12:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.